Fidelity Select Medical Tech and Devcs holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Fidelity Select Medical Technology and Devices Portfolio FSMEX
- NAV / 1-Day Return 55.82 / +0.70 %
- Total Assets 3.5B
-
Adj. Expense Ratio
0.620%
- Expense Ratio 0.620%
- Distribution Fee Level Low
- Share Class Type No Load
- Category Health
- Investment Style Mid Blend
- Min. Initial Investment 0
- Status Open
- TTM Yield 0.00
- Turnover 54%
USD | NAV as of Oct 03, 2026 | 1-Day Return as of Oct 03, 2026, 12:11 AM GMT+0
Morningstar’s Analysis FSMEX
Will FSMEX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 63.4
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Thermo Fisher Scientific Inc | 17.59 | 589M | Healthcare |
Danaher Corp | 14.04 | 470M | Healthcare |
Intuitive Surgical Inc | 5.29 | 177M | Healthcare |
Waters Corp | 4.27 | 143M | Healthcare |
West Pharmaceutical Services Inc | 4.08 | 136M | Healthcare |
Agilent Technologies Inc | 3.90 | 131M | Healthcare |
Boston Scientific Corp | 3.85 | 129M | Healthcare |
10x Genomics Inc Ordinary Shares - Class A | 3.73 | 125M | Healthcare |
Abbott Laboratories | 3.46 | 116M | Healthcare |
Stryker Corp | 3.19 | 107M | Healthcare |